Immunotherapy and Novel Targeted Drug Appear Beneficial in Women With Early-Stage ...
ESMO Congress 2024 studies show immunotherapy benefits in early-stage cervical and endometrial cancers, particularly in high-risk locally advanced cervical cancer and endometrial dMMR tumors. A novel antibody-drug conjugate targeting claudin 6 shows promising antitumor activity in ovarian and endometrial cancers.
Reference News
Immunotherapy and Novel Targeted Drug Appear Beneficial in Women With Early-Stage ...
ESMO Congress 2024 studies show immunotherapy benefits in early-stage cervical and endometrial cancers, particularly in high-risk locally advanced cervical cancer and endometrial dMMR tumors. A novel antibody-drug conjugate targeting claudin 6 shows promising antitumor activity in ovarian and endometrial cancers.